CORT Corcept Therapeutics Incorporated
Healthcare$60.36+0.23%ClosedMarket Cap: $6.48B
As of 2026-05-26
Valuation
P/E (TTM)
44.99
PEG
—
P/B
9.86
P/S
8.41
EV/EBITDA
-937.23
DCF Value
$68.93
FCF Yield
1.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
98.3%
Operating Margin
-1.1%
Net Margin
6.2%
ROE
7.5%
ROA
5.9%
ROIC
-1.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $164.9M | 98.3% | $-49.6M | $-31.2M | $— | — |
| Q4 null | $202.1M | 98.7% | $4.5M | $24.3M | $— | — |
| FY null | $761.4M | 98.3% | $44.8M | $99.7M | $— | — |
| Q3 null | $207.6M | 97.8% | $10.2M | $19.7M | $— | — |
| Q2 null | $194.4M | 98.2% | $26.7M | $35.1M | $— | — |
| Q1 null | $157.2M | 98.5% | $3.4M | $20.5M | $— | — |
| Q4 null | $181.9M | 98.4% | $25.3M | $30.4M | $— | — |
| FY null | $675.0M | 98.4% | $137.0M | $139.7M | $— | — |
| Q3 null | $182.5M | 98.4% | $46.6M | $46.7M | $— | — |
| Q2 null | $163.8M | 98.5% | $35.6M | $35.5M | $— | — |
| Q1 null | $146.8M | 98.3% | $29.5M | $27.8M | $— | — |
| Q4 2023 | $135.4M | 98.6% | $31.7M | $31.4M | $0.28 | — |